Why the study?
Do coronary plaque characteristics and high-sensitivity C-reactive protein levels differ between symptomatic patients with and without type 2 diabetes?
Do coronary plaque characteristics and high-sensitivity C-reactive protein levels differ between symptomatic patients with and without type 2 diabetes?
Symptomatic patients with type 2 diabetes have a significantly higher burden of diffuse calcified coronary plaques and higher hs-CRP levels compared to non-diabetics, suggesting a potential role for combined CTA and hs-CRP in risk stratification.
Little is known regarding plaque distribution, composition, and the association with inflammation in type 2 diabetes mellitus (DM2). This study aimed to assess the relationship between coronary plaque subtypes and high-sensitivity C-reactive protein levels. Coronary CTA were performed in 98 symptomatic DM2 patients and 107 non-DM2 patients using a 256-slice CT. The extent and types of plaque as well as luminal narrowing were evaluated. Patients with DM2 were more likely to have significant stenosis (>50%) with calcified plaques in at least one coronary segment (p < 0.01); the prevalence rates of diffuse calcified plaques in the DM2 and non-DM2 groups were 31.6% and 4.7%, respectively (p < 0.01). Plasma hs-CRP levels in DM2 with calcified plaques were higher compared with values obtained for the non-DM2 group (p < 0.01). In conclusion, combination of coronary CTA and hs-CRP might improve risk stratification in symptomatic DM2 patients.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: